Press Releases

Press Releases Jun 08, 2021

ReAlta Life Sciences Receives $3.2 Million Grant...

RLS-0071 is in development for treatment of Acute Lung Injury (ALI) and Hypoxic Ischemic Encephalopathy (HIE) Norfolk, VA, June 8,...

Read More
Press Releases May 18, 2021

ReAlta Life Sciences Expands Phase 1 Clinical...

RLS-0071 is in development for treatment of Acute Lung Injury (ALI) and Hypoxic Ischemic Encephalopathy (HIE) Norfolk, VA, May...

Read More
Press Releases Apr 28, 2021

ReAlta Life Sciences Closes $20 Million Series...

Proceeds to Fund Programs Addressing Acute Lung Injury (ALI) and Hypoxic Ischemic Encephalopathy (HIE) Norfolk, VA, April 28, 2021 —...

Read More
Press Releases Apr 09, 2021

ReAlta Life Sciences to Participate in the...

Norfolk, VA, April 9, 2021 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive...

Read More
Press Releases Feb 16, 2021

ReAlta Life Sciences Doses First Subject In...

Norfolk, VA, February 16, 2021 – ReAlta Life Sciences, Inc. (“ReAlta”), a company addressing life-threatening diseases through harnessing the power...

Read More
Press Releases Dec 03, 2020

ReAlta Life Sciences Announces EMA Orphan Drug...

Norfolk, VA, December 3, 2020 — ReAlta Life Sciences, Inc., today announced that the European Medicines Agency (EMA) has granted Orphan...

Read More
Press Releases Jul 28, 2020

ReAlta Life Sciences Announces U.S. FDA Clearance...

Norfolk, VA, July 28, 2020 — ReAlta Life Sciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has...

Read More
Press Releases Jun 29, 2020

ReAlta Life Sciences to Participate In Oppenheimer’s...

Norfolk, VA, June 29, 2020 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer,...

Read More
Press Releases Apr 21, 2020

ReAlta Life Sciences Closes $14 Million Series...

Norfolk, VA, April 21, 2020 — ReAlta Life Sciences, Inc., today announced that it has successfully closed an oversubscribed Series A2...

Read More